Biotech Hammered On 'Shockingly Poor' Report For Breast Cancer Drug [Investor's Business Daily]
Puma Biotechnology Inc (PBYI)
Last puma biotechnology inc earnings: 2/20 04:07 pm
Check Earnings Report
US:NYSE Investor Relations:
pumabiotechnology.com/ir.html
Company Research
Source: Investors Business Daily
Related news 3/29/2019 Puma Biotechnology shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 84. Stock Upgrades: Puma Biotechnology Shows Rising Relative Strength Stock Upgrades: Puma Biotechnology Shows Rising Relative Strength Is This 'As Good As It Gets' For This Biotech's Breast Cancer Drug? Biotech Stock Reverses Gains Despite 'Surprisingly Strong' Report IBD Rating Upgrades: Puma Biotechnology Flashes Improved Price Strength How These 3 Biotech Stocks Are Prompting A Group-Wide Surge Puma Biotechnology Scores Relative Strength Rating Upgrade; Hits Key Threshold Stocks Generating Improved Relative Strength: Puma Biotechnology Puma Biotechnology ( PBYI ) stock was hammered Friday after sales of breast cancer treatment Nerlynx lagged the Street by north of $20 million despite a first-quarter price hike. Nerlynx sales came in at $45.6 million, well below expectations for $64.5 million to $6
Show less
Read more
Impact Snapshot
Event Time:
PBYI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBYI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBYI alerts
High impacting Puma Biotechnology Inc news events
Weekly update
A roundup of the hottest topics
PBYI
News
- What's in Store for Puma Biotechnology (PBYI) in Q1 Earnings? [Yahoo! Finance]Yahoo! Finance
- Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial ResultsBusiness Wire
- Puma Biotech (PBYI) Stock Dips While Market Gains: Key Facts [Yahoo! Finance]Yahoo! Finance
- Puma Biotechnology, Inc. (NASDAQ: PBYI) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year [Yahoo! Finance]Yahoo! Finance
PBYI
Earnings
- 2/29/24 - Miss
PBYI
Analyst Actions
- 2/13/24 - HC Wainwright
PBYI
Sec Filings
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form ARS
- 4/26/24 - Form DEF
- PBYI's page on the SEC website